Ernexa Therapeutics (ERNAW) Shares Outstanding (Diluted) (2010 - 2026)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Ernexa Therapeutics | 49,449.40 | 49,449.40 | - | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 792,000.00 |
| Dec 31, 2025 | 6.31 Mn |
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | 909,845.00 |
| Sep 30, 2024 | 360,685.00 |
| Jun 30, 2024 | 360,685.00 |
| Mar 31, 2024 | 360,685.00 |
| Dec 31, 2023 | 354,284.00 |
| Sep 30, 2023 | 360,685.00 |
| Jun 30, 2023 | 353,551.00 |
| Mar 31, 2023 | 341,817.00 |
| Dec 31, 2022 | 203,410.00 |
| Sep 30, 2022 | 196,076.00 |
| Jun 30, 2022 | 196,010.00 |
| Mar 31, 2022 | 178,742.00 |
| Dec 31, 2021 | 144,361.00 |
| Sep 30, 2021 | 168,488.00 |